AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AXSM Filings
Filing Date
Form Description
Form Type
2025-12-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-03
Form 144 - Report of proposed sale of securities
Ownership
2025-12-03 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-05
Form 144 - Report of proposed sale of securities
Ownership
2025-11-05 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-05
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-05 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-04
Form 144 - Report of proposed sale of securities
Ownership
2025-11-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-03
Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-03 · Earnings Call
Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript
2025-11-03
Form 144 - Report of proposed sale of securities
Ownership
2025-11-03 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-03
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-11-03 ·
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
